BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22224032)

  • 1. Preparation and characterization of pioglitazone cyclodextrin inclusion complexes.
    Pandit V; Gorantla R; Devi K; Pai R; Sarasija S
    J Young Pharm; 2011 Oct; 3(4):267-74. PubMed ID: 22224032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid-state characterization and in vitro dissolution behavior of lorazepam: Hydroxypropyl-β-cyclodextrin inclusion complex.
    Patel R; Patel M
    Drug Discov Ther; 2010 Dec; 4(6):442-52. PubMed ID: 22491310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds.
    Fernandes CM; Teresa Vieira M; Veiga FJ
    Eur J Pharm Sci; 2002 Feb; 15(1):79-88. PubMed ID: 11803134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the hydrophobic nature of triacetyl-beta-cyclodextrin on the complexation with nicardipine hydrochloride: physicochemical and dissolution properties of the kneaded and spray-dried complexes.
    Fernandes CM; Veiga FJ
    Chem Pharm Bull (Tokyo); 2002 Dec; 50(12):1597-602. PubMed ID: 12499598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and hypoglycemic activity of pioglitazone-cyclodextrin inclusion complexes.
    Elbary AA; Kassem MA; Abou Samra MM; Khalil RM
    Drug Discov Ther; 2008 Apr; 2(2):94-107. PubMed ID: 22504505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, characterization and in vitro dissolution study of Nitrazepam: Cyclodextrin inclusion complex.
    Patel JS; Patel RP
    J Pharm Bioallied Sci; 2012 Mar; 4(Suppl 1):S106-7. PubMed ID: 23066180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physico-chemical characterization and in vitro dissolution assessment of clonazepam-cyclodextrins inclusion compounds.
    Patel R; Purohit N
    AAPS PharmSciTech; 2009; 10(4):1301-12. PubMed ID: 19885735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of quercetin and rutin cyclodextrin inclusion complexes.
    Sri KV; Kondaiah A; Ratna JV; Annapurna A
    Drug Dev Ind Pharm; 2007 Mar; 33(3):245-53. PubMed ID: 17454057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of olanzapine and methyl-β-cyclodextrin complexes using a single-step, organic solvent-free supercritical fluid process: An approach to enhance the solubility and dissolution properties.
    Rudrangi SR; Trivedi V; Mitchell JC; Wicks SR; Alexander BD
    Int J Pharm; 2015 Oct; 494(1):408-16. PubMed ID: 26315120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
    Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
    Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.
    Semalty M; Panchpuri M; Singh D; Semalty A
    Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
    Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
    J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-cyclodextrin complexes of celecoxib: molecular-modeling, characterization, and dissolution studies.
    Reddy MN; Rehana T; Ramakrishna S; Chowdhary KP; Diwan PV
    AAPS PharmSci; 2004 Mar; 6(1):E7. PubMed ID: 15198508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spray dried nanospheres for inclusion complexes of cefpodoxime proxetil with β-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin and methyl-β-cyclodextrin: improved dissolution and enhanced antibacterial activity.
    Yurtdaş-Kırımlıoğlu G
    Drug Dev Ind Pharm; 2021 Aug; 47(8):1261-1278. PubMed ID: 34606394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes.
    Cirri M; Rangoni C; Maestrelli F; Corti G; Mura P
    Drug Dev Ind Pharm; 2005 Aug; 31(7):697-707. PubMed ID: 16207617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of pioglitazone cyclodextrin complexes: Molecular modeling to in vivo evaluation.
    Bramhane DM; Kulkarni PA; Martis EA; Pissurlenkar RR; Coutinho EC; Nagarsenker MS
    J Pharm Bioallied Sci; 2016; 8(2):161-9. PubMed ID: 27134470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin.
    Ribeiro A; Figueiras A; Santos D; Veiga F
    AAPS PharmSciTech; 2008; 9(4):1102-9. PubMed ID: 18975116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of tolbutamide-hydroxypropyl-gamma-cyclodextrin interaction in solution and solid state.
    Veiga MD; Ahsan F
    Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):793-7. PubMed ID: 10866138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.